drugset / Trial / NCT02582996
Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks
RandomizedParallel-groupOpen-labelTreatment
Summary
National clinical trials, phase III, randomized, open, parallel, study of superiority, in which three hundred thirty-six (336) participants of both sexes, aged between 18 and 65 years will be randomly allocated to one of two treatment groups. The Group 01 will use Cefalium® and group 02 will use Tylenol®.
Timeline
- Start
- 2020-04
- Primary completion
- 2021-04
- Completion
- 2021-06
Outcome
Outcome not reported
Stopped (Business): “Strategic reasons of the company”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | — | — |
| Subject | Caffeine | Small molecule | — | — |
| Subject | Dihydroergotamine | Small molecule | — | — |
| Subject | Metoclopramide | Small molecule | — | — |